<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(1)</volume><submitter>Lee NC</submitter><journal>Blood advances</journal><pagination>208-212</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12805271</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Danazol treatment for telomere biology disorders: long-term results of a phase 1/2 study.</pubmed_title><pmcid>PMC12805271</pmcid><pubmed_authors>Kajigaya S</pubmed_authors><pubmed_authors>Aubert G</pubmed_authors><pubmed_authors>Lee NC</pubmed_authors><pubmed_authors>Groarke EM</pubmed_authors><pubmed_authors>Machado T</pubmed_authors><pubmed_authors>Paul S</pubmed_authors><pubmed_authors>Lotter J</pubmed_authors><pubmed_authors>Alemu L</pubmed_authors><pubmed_authors>Young NS</pubmed_authors><pubmed_authors>Wu CO</pubmed_authors><pubmed_authors>Raffo DQ</pubmed_authors><pubmed_authors>Patel BA</pubmed_authors><pubmed_authors>Gutierrez-Rodrigues F</pubmed_authors><pubmed_authors>Shalhoub R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Danazol treatment for telomere biology disorders: long-term results of a phase 1/2 study.</name><description/><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-15T11:22:08.701Z</modification><creation>2026-07-04T03:11:59.259Z</creation></dates><accession>S-EPMC12805271</accession><cross_references><pubmed>41115243</pubmed><doi>10.1182/bloodadvances.2025017860</doi></cross_references></HashMap>